Aims/hypothesis To provide a systematic overview of the current body of evidence on high-
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …

Abstract Background Since December 2019, the world has struggled with the COVID‐19
pandemic. Even after the introduction of various vaccines, this disease still takes a …

Background The renin-angiotensin-aldosterone system was shown to be activated in severe
COVID-19 infection. We aimed to investigate the relationship between angiotensin …

Patients with Covid-19 place new challenges on the management of type 2 diabetes,
including the questions of whether glucose-lowering therapy should be adjusted during …

AIMS To assess if patients with type 2 diabetes mellitus (DM2) are: a) at excess risk of
undergoing testing, contracting, and dying from SARS-CoV-2 infection compared to the …

Purpose While obesity is related to more severe outcomes of coronavirus disease 2019
(COVID-19), factors leading to poor prognosis still remain unclear. The present study …

SARS-CoV-2, a newly emerged virus described for the first time in late 2019, affects multiple
organs in humans, including the pancreas. Here, we present the bilateral link between the …

Introduction: COVID-19 disease has a worse prognosis in patients with diabetes, but
comparative data about the course of COVID-19 in patients with type 1 (T1DM) and type 2 …

Introduction To investigate the effect of preexisting treatment with dipeptidyl peptidase-4
inhibitors (DPP-4is) on COVID-19-related hospitalization and mortality in patients with type 2 …

Introduction Diabetes is one of the comorbidities associated with poor prognosis in
hospitalized COVID-19 patients. In this nationwide retrospective study, we evaluated the risk …